Clinical trials: Melasma

Melasma

Curcuma Xanthorriza Roxb. 10% Cream for Melasma

• Unknown status
• Age: All ages
• Early Phase 1

Melasma is an acquired hyperpigmentation disorder with a multifactorial etiology and complex pathogenesis that can significantly diminish the quality of life for affected patients.

Trial name

NCT06153134

Testing

10% Curcuma xanthorriza Roxb., 2% Kojic Acid

Where

Indonesia

Volunteers

15 people, healthy volunteers welcome

Sponsor

Universitas Padjadjaran